Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus‐6B reactivation

Chronic/recurrent behaviour may be encountered in some distinct atypical or malignant lymphoproliferations, while recurrences are not generally observed in reactive/benign lymphadenopathies. We retrospectively analysed a consecutive series of 486 human immunodeficiency virus‐negative adults, who underwent lymphadenectomy. Neoplastic and benign/reactive histopathological pictures were documented in 299 (61·5%) and 187 (38·5%) cases, respectively. Of note, seven of the 111 (6·3%) patients with benign lymphadenopathy without well‐defined aetiology, showed chronic/recurrent behaviour, without constitutional symptoms. Enlarged lymph nodes were round in shape and hypoechoic, mimicking lymphoma. Reactive follicular hyperplasia and paracortical expansion were observed. Human herpesvirus (HHV)‐6B positive staining in follicular dendritic cells (FDCs) was documented in all seven patients. Serological, molecular and immunological examinations suggested HHV‐6B reactivation. Among the remaining 104 cases with reactive lymphoid hyperplasia in the absence of well‐known aetiology and without recurrences, positivity for HHV‐6B on FDCs was found in three cases, whereas in seven further patients, a scanty positivity was documented in rare, scattered cells in inter‐follicular regions. Immunohistochemistry for HHV‐6A and HHV‐6B was invariably negative on 134 lymph nodes, with either benign pictures with known aetiology or malignant lymphoproliferative disorders, tested as further controls. Future studies are warranted to investigate a potential association between HHV‐6B reactivation and chronic/recurrent benign lymphadenopathy.

[1]  P. Zinzani,et al.  Angioimmunoblastic T-Cell Lymphoma. , 2017, Hematology/oncology clinics of North America.

[2]  K. Sun,et al.  HHV-6-associated acute lymphadenitis in immunocompetent patients: a case report and review of literature. , 2014, International journal of clinical and experimental pathology.

[3]  H. Agut,et al.  Classification of HHV-6A and HHV-6B as distinct viruses , 2014, Archives of Virology.

[4]  B. Nathwani,et al.  Follicular dendritic cells: origin, function, and different disease-associated patterns. , 2013, Human pathology.

[5]  U. Gerdemann,et al.  Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. , 2013, Blood.

[6]  S. Alexander,et al.  Progressive transformation of germinal centers in children and adolescents: An intriguing cause of lymphadenopathy , 2013, Pediatric blood & cancer.

[7]  L. Pantanowitz,et al.  Benign non‐infectious causes of lymphadenopathy: A review of cytomorphology and differential diagnosis , 2012, Diagnostic cytopathology.

[8]  S. Hudnall,et al.  Human herpesvirus 6 positive Reed–Sternberg cells in nodular sclerosis Hodgkin lymphoma , 2012, British journal of haematology.

[9]  G. Rossi,et al.  Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients. , 2011, Blood.

[10]  M. Mansukhani,et al.  Cytogenetic abnormalities in reactive lymphoid hyperplasia: byproducts of the germinal centre reaction or indicators of lymphoma? , 2011, Hematological oncology.

[11]  R. Shukla,et al.  Usefulness of ultrasonography for the evaluation of cervical lymphadenopathy , 2011, World journal of surgical oncology.

[12]  A. Komaroff,et al.  Review Part 3: Human herpesvirus‐6 in multiple non‐neurological diseases , 2010, Journal of medical virology.

[13]  J. B. Oliveira,et al.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. , 2010, Blood.

[14]  P. Preux,et al.  Involvement of Human Herpesvirus-6 Variant B in Classic Hodgkin's Lymphoma via DR7 Oncoprotein , 2010, Clinical Cancer Research.

[15]  R. Ferner,et al.  Recurrent Kikuchi-Fujimoto disease , 2010, BMJ Case Reports.

[16]  M. Luppi,et al.  HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? , 2010, Leukemia & lymphoma.

[17]  K. Naresh,et al.  Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)‐latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T‐cell response , 2010, European journal of haematology.

[18]  M. Ogata Human herpesvirus 6 in hematological malignancies. , 2009, Journal of clinical and experimental hematopathology : JCEH.

[19]  R. Gascoyne,et al.  Atypical lymphoid hyperplasia mimicking lymphoma. , 2009, Hematology/oncology clinics of North America.

[20]  M. Luppi,et al.  Prevalence of Human Herpesvirus‐6 Chromosomal Integration (CIHHV‐6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  G. Rossi,et al.  HHV-6A in syncytial giant-cell hepatitis. , 2008, The New England journal of medicine.

[22]  H. Einsele,et al.  Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT , 2008, Bone Marrow Transplantation.

[23]  J. Cyster,et al.  Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. , 2008, Seminars in immunology.

[24]  R. Hamoudi,et al.  Angioimmunoblastic T‐cell lymphoma: histological progression associates with EBV and HHV6B viral load , 2007, British journal of haematology.

[25]  H. Agut,et al.  Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  M. Migaldi,et al.  Post‐mortem diagnosis of encephalitis in a 75‐year‐old man associated with human herpesvirus‐6 variant A , 2005, Journal of medical virology.

[27]  K. Ward The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[28]  A. Wald,et al.  A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.

[29]  E. Jaffe,et al.  Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults , 2004, Modern Pathology.

[30]  A. Skarin,et al.  Clinical mimics of lymphoma. , 2004, The oncologist.

[31]  C. Mecucci,et al.  Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors , 2003, Nature Medicine.

[32]  A. Norman,et al.  Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients , 2003, British Journal of Cancer.

[33]  P. Ljungman β-Herpesvirus Challenges in the Transplant Recipient , 2002 .

[34]  R. L. Ferrer,et al.  Lymphadenopathy: differential diagnosis and evaluation. , 1998, American family physician.

[35]  R. Marasca,et al.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. , 1998, The American journal of pathology.

[36]  P. Barozzi,et al.  An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection , 1996, Journal of the Neurological Sciences.

[37]  A. Lakeman,et al.  Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines , 1994, The Journal of experimental medicine.

[38]  W. Siegert,et al.  Primary human herpesvirus 6 infection in an adult. , 1993, The New England journal of medicine.

[39]  M. Kikuchi,et al.  Analysis of human herpes virus-6 genomes in lymphoid malignancy in Japan. , 1993, Journal of clinical pathology.

[40]  R. Marasca,et al.  Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. , 1993, Leukemia research.

[41]  K. Akashi,et al.  Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. , 1993, The New England journal of medicine.

[42]  J. Gray,et al.  Avidity of IgG antibodies to human herpesvirus‐6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross‐reactivity with other herpesviruses , 1993, Journal of medical virology.

[43]  T. Yoshikawa,et al.  IgM Neutralizing Antibody Responses to Human Herpesvirus‐6 in Patients with Exanthem Subitum or Organ Transplantation , 1992, Microbiology and immunology.

[44]  N. Harris,et al.  Florid Progressive Transformation of Germinal Centers: A Syndrome Affecting Young Men, Without Early Progression to Nodular Lymphocyte Predominance Hodgkin's Disease , 1992, The American journal of surgical pathology.

[45]  S. Ferrari,et al.  Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. , 1991, Blood.

[46]  R. Saltzman,et al.  The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. , 1990, American journal of clinical pathology.

[47]  J. Niederman,et al.  CLINICAL AND SEROLOGICAL FEATURES OF HUMAN HERPESVIRUS-6 INFECTION IN THREE ADULTS , 1988, The Lancet.

[48]  J. Bienenstock,et al.  THIACETAZONE IN TUBERCULOSIS. , 1963, Lancet.

[49]  L. Weiss,et al.  Benign lymphadenopathies , 2013, Modern Pathology.

[50]  J. Maciejewski,et al.  Human Cytomegalovirus, Human Herpesvirus 8 and Other Herpesviruses (Part III, Section 2, Chapter 75) , 2005 .

[51]  P. Ljungman Beta-herpesvirus challenges in the transplant recipient. , 2002, The Journal of infectious diseases.

[52]  P. Gobbi,et al.  Diagnostic approach to lymph node enlargement. , 1999, Haematologica.

[53]  immunotherapeutic strategies with , 2022 .